January 4, 2022
The US Food and Drug Administration has approved levoketoconazole (Recorlev, Xeris Biopharma) for the treatment of endogenous hypercortisolemia in adults with Cushing syndrome for whom surgery […]
December 29, 2021
The US Food and Drug Administration (FDA) has approved Eli Lilly’s biosimilar version of insulin glargine, Rezvoglar KwikPen. The new formulation is the second long-acting glargine […]
December 28, 2021
The Food and Drug Administration has approved tralokinumab for the treatment of moderate to severe atopic dermatitis (AD) in adults whose disease is not well controlled […]
December 28, 2021
Patients with cancer remain vulnerable to breakthrough COVID-19 infection after vaccination and most experience severe outcomes, according to a review of patient data from the international […]
December 28, 2021
Padagis US LLC has initiated a nationwide recall of certain lots of nitroglycerin lingual spray due to a possible defective delivery system. “Out of an abundance […]
December 23, 2021
The US Food and Drug Administration (FDA) has approved secukinumab (Cosentyx, Novartis) for the treatment of active enthesitis-related arthritis (ERA) in children and adolescents age 4 years […]
December 23, 2021
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The US Food and Drug Administration (FDA) granted emergency use authorization to […]
December 22, 2021
Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The FDA on Wednesday granted emergency use authorization of a new antiviral pill to […]
December 21, 2021
The US Food and Drug Administration (FDA) has cleared for marketing the Philips CavaClear Laser Sheath, the first laser-based device to facilitate removal of inferior vena […]